PRESS RELEASE published on 08/01/2023 at 13:00, 2 years 10 months ago CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK
PRESS RELEASE published on 07/14/2023 at 13:00, 2 years 11 months ago CureVac Announces Update to the Management Team
PRESS RELEASE published on 07/13/2023 at 13:00, 2 years 11 months ago CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights
PRESS RELEASE published on 06/20/2023 at 13:05, 3 years ago CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma
PRESS RELEASE published on 06/20/2023 at 13:00, 3 years ago CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board
PRESS RELEASE published on 06/19/2023 at 17:30, 3 years ago CureVac Announces Voting Results of General Meeting
PRESS RELEASE published on 05/30/2023 at 13:00, 3 years ago CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update
PRESS RELEASE published on 05/19/2023 at 13:00, 3 years 1 month ago CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech
PRESS RELEASE published on 05/08/2023 at 13:00, 3 years 1 month ago CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK
PRESS RELEASE published on 04/25/2023 at 13:00, 3 years 1 month ago CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update
Published on 06/20/2026 at 01:00, 2 days 2 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 3 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 22 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 1 hour ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 3 days 1 hour ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 1 day 5 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 21 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 6 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 6 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 2 days 8 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 2 days 7 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 7 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 7 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 7 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
